Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Walton

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Radiology|September 1, 1979
Exercise radionuclide ejection fraction: correlation with exercise contrast ventriculographyT J Brady, K Lo, J H Thrall, et al.
The American Journal of Cardiology|December 1, 1984
Assessment of potentially salvageable myocardium during acute myocardial infarction: use of postextrasystolic potentiationJ M Hodgson, W W O'Neill, N Laufer, et al.
Circulation|February 1, 1989
Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery diseaseS W Werns, J A Walton, H H Hsia, et al.
Journal of the American College of Cardiology|August 1, 1987
Quantitative measurement of coronary flow during medical revascularization (thrombolysis or angioplasty) in patients with acute infarctionJ M Nicklas, E A Diltz, W W O'Neill, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1980
Segmental wall-motion analysis in the right anterior oblique projection: comparison of exercise equilibrium radionuclide ventriculography and exercise contrast ventriculographyT J Brady, J H Thrall, J W Keyes, et al.
Journal of the American College of Cardiology|April 1, 1989
Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: report of an initial experienceS G Ellis, W W O'Neill, E R Bates, et al.
American Heart Journal|January 1, 1988
Infarct vessel status after intravenous tissue plasminogen activator and acute coronary angioplasty: prediction of clinical outcomeC L Grines, E J Topol, E R Bates, et al.
Laval Medical|February 1, 1970
Transplantation of the human heartD R Khan, E W Reynolds, J A Walton, et al.
The American Journal of Cardiology|September 1, 1988
Coronary revascularization after intravenous tissue plasminogen activator for unstable angina pectoris: results of a randomized, double-blind, placebo-controlled trialE J Topol, J M Nicklas, N H Kander, et al.
Journal of the American College of Cardiology|March 1, 1992
Cardiogenic shock complicating acute myocardial infarction: the use of coronary angioplasty and the integration of the new support devices into patient managementG M Gacioch, S G Ellis, L Lee, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Radiology|September 1, 1979
Exercise radionuclide ejection fraction: correlation with exercise contrast ventriculographyT J Brady, K Lo, J H Thrall, et al.
The American Journal of Cardiology|December 1, 1984
Assessment of potentially salvageable myocardium during acute myocardial infarction: use of postextrasystolic potentiationJ M Hodgson, W W O'Neill, N Laufer, et al.
Circulation|February 1, 1989
Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery diseaseS W Werns, J A Walton, H H Hsia, et al.
Journal of the American College of Cardiology|August 1, 1987
Quantitative measurement of coronary flow during medical revascularization (thrombolysis or angioplasty) in patients with acute infarctionJ M Nicklas, E A Diltz, W W O'Neill, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1980
Segmental wall-motion analysis in the right anterior oblique projection: comparison of exercise equilibrium radionuclide ventriculography and exercise contrast ventriculographyT J Brady, J H Thrall, J W Keyes, et al.
Journal of the American College of Cardiology|April 1, 1989
Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: report of an initial experienceS G Ellis, W W O'Neill, E R Bates, et al.
American Heart Journal|January 1, 1988
Infarct vessel status after intravenous tissue plasminogen activator and acute coronary angioplasty: prediction of clinical outcomeC L Grines, E J Topol, E R Bates, et al.
Laval Medical|February 1, 1970
Transplantation of the human heartD R Khan, E W Reynolds, J A Walton, et al.
The American Journal of Cardiology|September 1, 1988
Coronary revascularization after intravenous tissue plasminogen activator for unstable angina pectoris: results of a randomized, double-blind, placebo-controlled trialE J Topol, J M Nicklas, N H Kander, et al.
Journal of the American College of Cardiology|March 1, 1992
Cardiogenic shock complicating acute myocardial infarction: the use of coronary angioplasty and the integration of the new support devices into patient managementG M Gacioch, S G Ellis, L Lee, et al.
Pageof 5